April 2026
1. PANUNZI S, Russo S, Pompa M, De Gaetano A, et al
   Personalizing bariatric metabolic surgery: Predictors of weight-loss success and risk of weight recurrence.
   Metabolism. 2026;177:156495.
   

   >> Share

   
   February 2026
2. ZHOU Y, Dai Y, Qin M, Li Y, et al
   FAM83A acts as an amplifier for lipogenic signaling to facilitate the pathogenesis of metabolic dysfunction-associated steatohepatitis.
   Metabolism. 2026;175:156462.
   

   >> Share

   
   
3. MARKAKIS K, Abadi LF, Kombe AK, Christodoulides M, et al
   HDL dysfunction: a role in the pathogenesis of cardiometabolic syndrome in chronic HIV infection?
   Metabolism. 2026;175:156432.
   

   >> Share

   
   December 2025
4. FAN G, Guo W, Lu J, He Y, et al
   CADD-engineered peptide protacs efficiently target PCSK9 for hypercholesterolemia in vivo.
   Metabolism. 2025 Dec 23:156485. doi: 10.1016/j.metabol.2025.156485.
   

   >> Share

   
   October 2025
5. LI L, Wang Y, Du Z, Yu H, et al
   Hepatic aconitase 1 redirects citrate flux to suppress lipogenesis and ameliorate hypercholesterolemia.
   Metabolism. 2025 Oct 7:156417. doi: 10.1016/j.metabol.2025.156417.
   

   >> Share

   
   July 2025
6. WANG Y, Wu Y, Jiang H, Li S, et al
   L-Kynurenine activates the AHR-PCSK9 pathway to mediate the lipid metabolic and ovarian dysfunction in polycystic ovary syndrome.
   Metabolism. 2025;168:156238.
   

   >> Share

   
   March 2025
7. DE MOURA DE SOUZA M, Mendes BX, Defante MLR, de Athayde de Hollanda Morais BA, et al
   Apolipoprotein C-III inhibitors for the treatment of hypertriglyceridemia: A meta-analysis of randomized controlled trials.
   Metabolism. 2025 Mar 10:156187. doi: 10.1016/j.metabol.2025.156187.
   

   >> Share

   
   November 2024
8. CONGUR I, Mingrone G, Guan K
   Targeting endoplasmic reticulum stress as a potential therapeutic strategy for diabetic cardiomyopathy.
   Metabolism. 2024 Nov 6:156062. doi: 10.1016/j.metabol.2024.156062.
   

   >> Share

   
   September 2024
9. JEONG JH, Kim YG, Han KD, Roh SY, et al
   Association of fatty liver index with sudden cardiac arrest in young adults.
   Metabolism. 2024;158:155981.
   

   >> Share

   
   
10. DANPANICHKUL P, Suparan K, Dutta P, Kaeosri C, et al
    Disparities in metabolic dysfunction-associated steatotic liver disease and cardiometabolic conditions in low and lower middle-income countries: a systematic analysis from the global burden of disease study 2019.
    Metabolism. 2024;158:155958.
    

    >> Share

    
    July 2024
11. HAGVE M, Pereira SL, Walker DK, Engelen MPKJ, et al
    Statin treatment reduces leucine turnover, but does not affect endogenous production of beta-hydroxy-beta-methylbutyrate (HMB).
    Metabolism. 2024;156:155920.
    

    >> Share

    
    June 2024
12. EZHILARASAN D
    Deciphering the molecular pathways of saroglitazar: A dual PPAR alpha/gamma agonist for managing metabolic NAFLD.
    Metabolism. 2024;155:155912.
    

    >> Share

    
    April 2024
13. ZELJKOVIC A, Vekic J, Stefanovic A
    Obesity and dyslipidemia in early life: Impact on cardiometabolic risk.
    Metabolism. 2024;156:155919.
    

    >> Share

    
    November 2023
14. ZUO F, Wang Y, Xu X, Ding R, et al
    CCDC92 deficiency ameliorates podocyte lipotoxicity in diabetic kidney disease.
    Metabolism. 2023 Nov 10:155724. doi: 10.1016/j.metabol.2023.155724.
    

    >> Share

    
    July 2023
15. WANG YD, Wu LL, Mai YN, Wang K, et al
    miR-32-5p induces hepatic steatosis and hyperlipidemia by triggering de novo lipogenesis.
    Metabolism. 2023 Jul 12:155660. doi: 10.1016/j.metabol.2023.155660.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share